Bristol Myers Reports Patient Death in Early-Stage Cell Therapy Trial
Bristol Myers Squibb disclosed a patient death in an early-stage trial of its experimental CAR T-cell therapy. Its shares were down 2.5% in early trading.
Bristol Myers Squibb (NYSE:BMY) disclosed Friday that a patient died during an early-stage trial of its experimental CAR T-cell therapy. The drugmaker’s shares were down 2.5% in early trading.